After the screening on the HER2 overexpressing SKBR3 BC cells, the most active compounds 5 and 6 were chosen for other BC subtype cell models: the MDA-MB231 and the A17 (Figure 2S). The gene discussed is ERBB2; the disease is breast cancer.